INTERNATIONAL PATENT: NUWACELL BIOTECHNOLOGIES CO., LTD. FILES APPLICATION FOR "USE OF INTERLEUKIN-21 AND INTERLEUKIN-15 FOR ENHANCING SERIAL KILLING OF NATURAL KILLER CELL FOR CELL THERAPY AGAINST TARGET CELL"

GENEVA, Dec. 15 -- NUWACELL BIOTECHNOLOGIES CO., LTD. (Innovation Park Bldg H3, 2800 Innovation BlvdHefei, Anhui 230088) filed a patent application (PCT/CN2024/097606) for "USE OF INTERLEUKIN-21 AND INTERLEUKIN-15 FOR ENHANCING SERIAL KILLING OF NATURAL KILLER CELL FOR CELL THERAPY AGAINST TARGET CELL" on Jun 05, 2024. With publication no. WO/2025/251226, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): YU, Junying (Innovation Park Bldg H3, 2800 Innovation BlvdHefei, Anhui 230088), ZHOU, Tao (Innovation Park Bldg H3, 2800 ...